| Vorinostat studied in …STUDIED_INderived200 of 214show all (up to 200) |
|---|
| → studied in | NCT00972478Phase 1/Phase 2 · active not recruiting Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma · 214 trials list this drug (22 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01522976Phase 2 · active not recruiting Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia · 214 trials list this drug (22 active) | — | — | Myelodysplastic Syndrome,Chronic Myelomonocytic Leukemia,Myelodysplastic Syndrome with Excess Blasts+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02559778Phase 2 · recruiting Pediatric Precision Laboratory Advanced Neuroblastoma Therapy · 214 trials list this drug (22 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03150329Phase 1 · active not recruiting Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL. · 214 trials list this drug (22 active) | — | — | B-Cell Malignant Neoplasm,Classic Hodgkin Lymphoma,Transformed Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07261241Phase 2 · not yet recruiting NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab · 214 trials list this drug (22 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00268385Phase 1 · active not recruiting Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas · 214 trials list this drug (22 active) | — | — | Adult Mixed Glioma,Adult Anaplastic Astrocytoma,Adult Anaplastic Oligodendroglioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00336063Phase 1 · active not recruiting Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma · 214 trials list this drug (22 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma,Adult Nasal Type Extranodal NK/T-Cell Lymphoma,Nasopharyngeal Keratinizing Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00392353Phase 1/Phase 2 · active not recruiting Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia · 214 trials list this drug (22 active) | — | — | Myelodysplastic Syndrome,Myelodysplastic Syndrome with Ring Sideroblasts,Acute Erythroid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06145633Phase 2 · recruiting Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer · 214 trials list this drug (22 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03259503Phase 1 · completed Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant · 214 trials list this drug (22 active) | — | — | Hodgkin Lymphoma,T-Cell Non-Hodgkin Lymphoma,Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01587352Phase 2 · active not recruiting Vorinostat in Treating Patients With Metastatic Melanoma of the Eye · 214 trials list this drug (22 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01087554Phase 1 · active not recruiting Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer · 214 trials list this drug (22 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03843528Phase 1 · active not recruiting Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation · 214 trials list this drug (22 active) | — | — | Juvenile Myelomonocytic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02553460Phase 1/Phase 2 · active not recruiting Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I · 214 trials list this drug (22 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03117751Phase 2/Phase 3 · active not recruiting Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma · 214 trials list this drug (22 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05848687Phase 1/Phase 2 · recruiting TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II · 214 trials list this drug (22 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02943642Phase 2 · withdrawn Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides · 214 trials list this drug (22 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01281176Phase 1 · active not recruiting High-Dose or Low-Dose Vorinostat in Combination With Carboplatin or Paclitaxel in Treating Patients With Advanced Solid Tumors · 214 trials list this drug (22 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04308330Phase 1 · recruiting Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies · 214 trials list this drug (22 active) | — | — | Germ Cell Tumor,Hepatoblastoma,Wilms Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03742245Phase 1 · active not recruiting Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer · 214 trials list this drug (22 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00616967Phase 2 · active not recruiting Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer · 214 trials list this drug (22 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00875056Phase 2 · completed Study of Vorinostat (MK-0683) With Follicular Lymphoma (FL), Other Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL), or Mantle Cell Lymphoma (MCL) Participants (MK-0683-103) · 214 trials list this drug (22 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03842696Phase 1/Phase 2 · active not recruiting Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation · 214 trials list this drug (22 active) | — | — | Acute Leukemia,Myelodysplastic Syndrome,Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05317403Phase 1 · recruiting Venetoclax to Augment Epigenetic Modification and Chemotherapy · 214 trials list this drug (22 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02638090Phase 1/Phase 2 · active not recruiting Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC) · 214 trials list this drug (22 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03263936Phase 1 · completed Epigenetic Reprogramming in Relapse/Refractory AML · 214 trials list this drug (22 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03426891Phase 1 · completed Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma · 214 trials list this drug (22 active) | — | — | Glioblastoma,Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02836548Phase 1/Phase 2 · completed HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma · 214 trials list this drug (22 active) | — | — | Skin Neoplasm,Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00838929Phase 1 · completed Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain Metastases · 214 trials list this drug (22 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03332667Phase 1 · completed MIBG With Dinutuximab +/- Vorinostat · 214 trials list this drug (22 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05608369Phase 2 · withdrawn Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC · 214 trials list this drug (22 active) | — | — | Human Papillomavirus-Related Squamous Cell Carcinoma,Laryngeal Squamous Cell Carcinoma,Oral Cavity Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02420613Phase 1 · completed Vorinostat and Temsirolimus With or Without Radiation Therapy in Treating Younger Patients With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma · 214 trials list this drug (22 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02538510Phase 1/Phase 2 · completed Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery · 214 trials list this drug (22 active) | — | — | Head and Neck Squamous Cell Carcinoma,Salivary Gland Carcinoma,Major Salivary Gland Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02619253Phase 1 · completed Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma · 214 trials list this drug (22 active) | — | — | Bladder Neoplasm,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01413750Phase 2 · terminated Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer · 214 trials list this drug (22 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00555399Phase 1/Phase 2 · terminated Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM) · 214 trials list this drug (22 active) | — | — | Glioblastoma,WHO Grade 3 Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01728805Phase 3 · completed Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL · 214 trials list this drug (22 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878524Phase 1 · terminated Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial · 214 trials list this drug (22 active) | — | — | Hematopoietic and Lymphatic System Neoplasm,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01236560Phase 2/Phase 3 · completed Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma · 214 trials list this drug (22 active) | — | — | Brain Stem Glioma,Childhood Spinal Cord Neoplasm,Childhood Cerebral Anaplastic Astrocytoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04220008Phase 2 · withdrawn Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed Aggressive B-cell or T-cell Non-Hodgkin Lymphoma · 214 trials list this drug (22 active) | — | — | B-Cell Non-Hodgkin Lymphoma,T-Cell Non-Hodgkin Lymphoma,Transformed B-Cell Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02316340Phase 2 · completed Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer · 214 trials list this drug (22 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01193842Phase 1/Phase 2 · completed Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas · 214 trials list this drug (22 active) | — | — | Primary Effusion Lymphoma,AIDS-Related Primary Effusion Lymphoma,Diffuse Large B-Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04190056Phase 2 · terminated Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer · 214 trials list this drug (22 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01838187no longer available Expanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma · 214 trials list this drug (22 active) | — | — | Paraganglioma,Neuroblastoma,Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00455351Phase 1 · completed Vorinostat and Palliative Radiotherapy · 214 trials list this drug (22 active) | — | — | Malignant Pelvic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01019850Phase 1 · completed N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma · 214 trials list this drug (22 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01023737Phase 1 · completed Hydroxychloroquine + Vorinostat in Advanced Solid Tumors · 214 trials list this drug (22 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01174199Phase 1 · terminated Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer · 214 trials list this drug (22 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01879085Phase 1/Phase 2 · completed Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma · 214 trials list this drug (22 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02349867Phase 1 · completed Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer · 214 trials list this drug (22 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Carcinoma,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00127127Phase 1 · completed A Study of Vorinostat in Patients With Solid Tumors (MK-0683-029) · 214 trials list this drug (22 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00731731Phase 1/Phase 2 · completed Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · 214 trials list this drug (22 active) | — | — | Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02042989Phase 1 · completed MLN9708 and Vorinostat in Patients With Advanced p53 Mutant Malignancies · 214 trials list this drug (22 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02035137Phase 2 · completed 131I-MIBG Alone VS. 131I-MIBG With Vincristine and Irinotecan VS131I-MIBG With Vorinostat · 214 trials list this drug (22 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03713320Phase 2 · terminated SOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects With Mycosis Fungoides · 214 trials list this drug (22 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00785798Phase 1/Phase 2 · terminated Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas · 214 trials list this drug (22 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00867178Phase 1 · completed Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System · 214 trials list this drug (22 active) | — | — | Medulloblastoma,Pineoblastoma,Supratentorial Embryonal Tumor, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02083250Phase 1 · completed Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant · 214 trials list this drug (22 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01038388Phase 1 · completed A Study of the Combination Vorinostat With Lenalidomide, Bortezomib and Dexamethasone for Patients With Newly Diagnosed Multiple Myeloma · 214 trials list this drug (22 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01189266Phase 1/Phase 2 · completed Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma · 214 trials list this drug (22 active) | — | — | Anaplastic Astrocytoma,Anaplastic Oligoastrocytoma,Diffuse Intrinsic Pontine Glioma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01110876Phase 1/Phase 2 · terminated Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM) · 214 trials list this drug (22 active) | — | — | Glioblastoma,Malignant Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01617226Phase 2 · completed Randomised Study of Azacitidine Versus Azacitidine With Vorinostat in Patients With AML or High Risk MDS · 214 trials list this drug (22 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00773747Phase 3 · completed Study of Vorinostat (MK-0683) or Placebo, in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-088 AMN) · 214 trials list this drug (22 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00858234Phase 1 · completed Phase I Study of MK-0683 in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-098) · 214 trials list this drug (22 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00773838Phase 2 · completed Study of Vorinostat (MK0683), an Histone Deacetylase (HDAC) Inhibitor in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (MK-0683-095) · 214 trials list this drug (22 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01266057Phase 1 · completed Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer · 214 trials list this drug (22 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00324740Phase 1/Phase 2 · terminated Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer · 214 trials list this drug (22 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01169532Phase 1 · completed Ridaforolimus and Vorinostat in Treating Patients With Advanced Solid Tumors or Lymphoma · 214 trials list this drug (22 active) | — | — | Adult Solid Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00691210Phase 1 · completed Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies · 214 trials list this drug (22 active) | — | — | Hodgkin Lymphoma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00821951Phase 1 · completed Vorinostat in Combination With Palliative Radiotherapy for Patients With Non-Small Cell Lung Cancer · 214 trials list this drug (22 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00642954Phase 1 · completed Vorinostat (MK-0683, SAHA [Suberoylanilide Hydroxamic Acid]) + Lenalidomide + Dexamethasone in Multiple Myeloma (MM) (MK-0683-074) · 214 trials list this drug (22 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01483690Phase 1/Phase 2 · terminated A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL · 214 trials list this drug (22 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia,T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00128102Phase 3 · completed Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (MK-0683-014) · 214 trials list this drug (22 active) | — | — | Malignant Mesothelioma,Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00574587Phase 1/Phase 2 · completed Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy · 214 trials list this drug (22 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03509207Phase 2 · terminated Vorinostat (SAHA) in Uterine Sarcoma · 214 trials list this drug (22 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01175980Phase 2 · completed Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma · 214 trials list this drug (22 active) | — | — | Malignant Major Salivary Gland Neoplasm,Salivary Gland Carcinoma,Oral Cavity Adenoid Cystic Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01249443Phase 1 · terminated Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection · 214 trials list this drug (22 active) | — | — | Adult Solid Neoplasm,Malignant Breast Neoplasm,Malignant Esophageal Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02395627Phase 2 · terminated Reversing Therapy Resistance With Epigenetic-Immune Modification · 214 trials list this drug (22 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00729118Phase 1 · completed Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma · 214 trials list this drug (22 active) | — | — | Multiple Myeloma,Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00992446Phase 2 · completed Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma · 214 trials list this drug (22 active) | — | — | B-Cell Non-Hodgkin Lymphoma,Non-Hodgkin Lymphoma,T-Cell Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00918723Phase 1/Phase 2 · completed Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · 214 trials list this drug (22 active) | — | — | Chronic Lymphocytic Leukemia,Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00948064Phase 2 · completed Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) · 214 trials list this drug (22 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00262834Phase 2 · completed Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I -III Breast Cancer · 214 trials list this drug (22 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03022565early Phase 1 · withdrawn Vorinostat in Patients With Class 2 High Risk Uveal Melanoma · 214 trials list this drug (22 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01983969Phase 1/Phase 2 · completed Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma · 214 trials list this drug (22 active) | — | — | Malignant Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01720602NA · completed Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy · 214 trials list this drug (22 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00798720Phase 2 · completed Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung Cancer · 214 trials list this drug (22 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02589145Phase 1/Phase 2 · terminated Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype · 214 trials list this drug (22 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01059552Phase 1 · completed Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC) · 214 trials list this drug (22 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01118975Phase 1/Phase 2 · terminated GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers · 214 trials list this drug (22 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01084057Phase 1 · completed Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer · 214 trials list this drug (22 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01153672NA · completed Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy · 214 trials list this drug (22 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01075113Phase 1 · completed Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer · 214 trials list this drug (22 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00132067Phase 2 · completed Vorinostat in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cavity Cancer · 214 trials list this drug (22 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01064921Phase 1 · completed Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell Carcinoma · 214 trials list this drug (22 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00895934Phase 1/Phase 2 · completed Vorinostat, Azacitidine, and Gemtuzumab Ozogamicin for Older Patients With Relapsed or Refractory AML · 214 trials list this drug (22 active) | — | — | Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia with Maturation+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00121225Phase 2 · completed Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma · 214 trials list this drug (22 active) | — | — | Melanoma,Uveal Melanoma,Iris Melanoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02412475Phase 1 · terminated Epigenetic Reprogramming in Relapse AML · 214 trials list this drug (22 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01802333Phase 3 · completed Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia · 214 trials list this drug (22 active) | — | — | Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00958074Phase 2 · terminated Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma · 214 trials list this drug (22 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00918489Phase 2 · completed Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS) · 214 trials list this drug (22 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00735826NA · completed A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Aerodigestive Tract Cancer · 214 trials list this drug (22 active) | — | — | Malignant Head and Neck Neoplasm,Malignant Esophageal Neoplasm,Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02108002Phase 1 · completed Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only) · 214 trials list this drug (22 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00910000Phase 1/Phase 2 · terminated Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer · 214 trials list this drug (22 active) | — | — | Malignant Peritoneal Neoplasm,Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01790568Phase 2 · completed Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell Transplant · 214 trials list this drug (22 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01550224Phase 2 · completed Temozolomide Plus Vorinostat in Relapse/Refractory Acute Myeloid Leukemia (AML) · 214 trials list this drug (22 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00703664Phase 2 · completed Bortezomib and Vorinostat in Treating Patients With Recurrent Mantle Cell Lymphoma or Recurrent and/or Refractory Diffuse Large B-Cell Lymphoma · 214 trials list this drug (22 active) | — | — | Non-Hodgkin Lymphoma,Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00720876Phase 2 · completed Vorinostat and Rituximab in Treating Patients With Indolent Non-Hodgkin Lymphoma · 214 trials list this drug (22 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01266031Phase 1/Phase 2 · completed Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma · 214 trials list this drug (22 active) | — | — | Glioblastoma,Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01789255Phase 2 · completed Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies · 214 trials list this drug (22 active) | — | — | Hairy Cell Leukemia,Myelodysplastic Syndrome with Ring Sideroblasts,Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01422499Phase 1/Phase 2 · completed Vorinostat in Children · 214 trials list this drug (22 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01567709Phase 1 · completed Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma · 214 trials list this drug (22 active) | — | — | Anaplastic Large Cell Lymphoma,Hairy Cell Leukemia,Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02419755Phase 2 · terminated Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies · 214 trials list this drug (22 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00253630Phase 2 · completed Vorinostat in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma · 214 trials list this drug (22 active) | — | — | Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,Grade 3 Follicular Lymphoma,Mantle Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00138203Phase 2 · completed Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer · 214 trials list this drug (22 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01342757NA · completed Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma · 214 trials list this drug (22 active) | — | — | Adult Glioblastoma,Adult Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00744354Phase 1 · terminated Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple Myeloma · 214 trials list this drug (22 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00818649Phase 2 · terminated Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia · 214 trials list this drug (22 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00882206Phase 2 · terminated Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia · 214 trials list this drug (22 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01312818Phase 2 · terminated Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) · 214 trials list this drug (22 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00764517Phase 2 · completed Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's Lymphoma · 214 trials list this drug (22 active) | — | — | B-Cell Non-Hodgkin Lymphoma,Chronic Lymphocytic Leukemia,Indolent Adult Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01187446Phase 1/Phase 2 · terminated Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides · 214 trials list this drug (22 active) | — | — | Cutaneous Lymphoma,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00278395Phase 2 · completed Vorinostat in Treating Patients With Kidney Cancer · 214 trials list this drug (22 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00589472Phase 2 · completed Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer · 214 trials list this drug (22 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00946673Phase 1 · completed Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer · 214 trials list this drug (22 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma,Malignant Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00857324Phase 1/Phase 2 · terminated Study of Vorinostat Plus Melphalan and Prednisone (Zmp) in Advanced, Refractory Multiple Myeloma Patients · 214 trials list this drug (22 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00788112Phase 1 · completed Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast · 214 trials list this drug (22 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01130506Phase 1 · completed Decitabine, Vorinostat, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome · 214 trials list this drug (22 active) | — | — | Myelodysplastic Syndrome,Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01132911Phase 1 · completed A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas · 214 trials list this drug (22 active) | — | — | Lymphoma,Sarcoma,Wilms Tumor+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01339871Phase 1 · completed Study of Pazopanib and Vorinostat in Patients With Advanced Malignancies · 214 trials list this drug (22 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00662311Phase 1/Phase 2 · terminated Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By Surgery · 214 trials list this drug (22 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00673153Phase 2 · terminated Vorinostat and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · 214 trials list this drug (22 active) | — | — | Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia with Maturation+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00601718Phase 1/Phase 2 · completed Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma · 214 trials list this drug (22 active) | — | — | Anaplastic Large Cell Lymphoma,Non-Hodgkin Lymphoma,Adult Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00948688Phase 1/Phase 2 · terminated Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas · 214 trials list this drug (22 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00839956Phase 2 · completed Bortezomib and Vorinostat in Treating Patients With Multiple Myeloma Who Have Undergone Autologous Stem Cell Transplant · 214 trials list this drug (22 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01267240Phase 2 · terminated Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer · 214 trials list this drug (22 active) | — | — | Laryngeal Squamous Cell Carcinoma,Oral Cavity Squamous Cell Carcinoma,Hypopharyngeal Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00976183Phase 1/Phase 2 · terminated Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma · 214 trials list this drug (22 active) | — | — | Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01120834Phase 1/Phase 2 · completed Study of 5-azacitidine in Combination With Vorinostat in Patients With Relapsed or Refractory Diffuse Large b Cell Lymphoma (DLBCL) · 214 trials list this drug (22 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00750178Phase 1 · completed A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK0683 in Patients With Advanced Cancer (0683-008) · 214 trials list this drug (22 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01738646Phase 2 · completed Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients · 214 trials list this drug (22 active) | — | — | Glioblastoma,Malignant Glioma,Adult Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00719875Phase 1 · completed HDAC Inhibitor Vorinostat (SAHA) With Capecitabine (Xeloda) Using a New Weekly Dose Regimen for Advanced Breast Cancer · 214 trials list this drug (22 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00565227Phase 1 · terminated Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies. · 214 trials list this drug (22 active) | — | — | Lung Non-Small Cell Carcinoma,Urothelial Carcinoma,Malignant Bladder Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01501370Phase 2 · withdrawn Vorinostat Plus Lenalidomide and Dexamethasone or Lenalidomide Plus Dexamethasone in Multiple Myeloma Patients Who Experience Biochemical Relapse During Lenalidomide Maintenance Therapy · 214 trials list this drug (22 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01394354Phase 1/Phase 2 · completed Vorinostat in Combination With Bortezomib, Doxorubicin and Dexamethasone (VBDD) in Patients With Refractory or Relapsed Multiple Myeloma (MM) · 214 trials list this drug (22 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00423449Phase 1 · completed Clinical Trial of MK0683 in Combination With FDA Approved Cancer Drugs in Patients With Advanced NSCLC (MK0683-058) · 214 trials list this drug (22 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00324870Phase 1/Phase 2 · completed Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer · 214 trials list this drug (22 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01276717Phase 1 · completed Study of Carfilzomib and Vorinostat for Relapsed or Refractory Lymphoma · 214 trials list this drug (22 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01208454Phase 1 · completed Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma · 214 trials list this drug (22 active) | — | — | Neuroblastoma,Regional Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01421173Phase 1 · completed Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies · 214 trials list this drug (22 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00368875Phase 1/Phase 2 · completed Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer · 214 trials list this drug (22 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00127140Phase 1 · completed A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Malignant Lymphoma (0683-030) · 214 trials list this drug (22 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00479232Phase 1 · completed Phase I Trial of Vorinostat (MK-0683, SAHA) in Combination With Decitabine in Patients With AML or MDS (MK-0683-055 EXT1) · 214 trials list this drug (22 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00373490Phase 1 · completed A Study of Oral Suberoylanilide Hydroxamic Acid (Vorinostat) in Patients With Solid Tumors (0683-048) · 214 trials list this drug (22 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00632931Phase 1 · completed A Crossover Study to Assess the Effects of Vorinostat (MK0683, SAHA) in Patients With Advanced Cancer (0683-070)(COMPLETED) · 214 trials list this drug (22 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00121277Phase 1 · completed Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid Tumors · 214 trials list this drug (22 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00561418Phase 1 · completed Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma · 214 trials list this drug (22 active) | — | — | Lymphoma,Small Intestinal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00473889Phase 2/Phase 3 · terminated A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056) · 214 trials list this drug (22 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00983268Phase 1 · completed Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer · 214 trials list this drug (22 active) | — | — | Malignant Pancreatic Neoplasm,Periampullary Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00111813Phase 1 · completed Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1)) · 214 trials list this drug (22 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00907738Phase 2 · completed A Continuation Clinical Trial of Oral Vorinostat (MK-0683) in Advanced Cancers (MK-0683-007) · 214 trials list this drug (22 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00127101Phase 1 · terminated An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED) · 214 trials list this drug (22 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00771472Phase 1 · completed Vorinostat (MK-0683) Phase I Study in Cutaneous T-Cell Lymphoma (CTCL) Patients (MK-0683-089 EXT1) · 214 trials list this drug (22 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00132002Phase 2 · terminated Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer · 214 trials list this drug (22 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00656617Phase 2 · completed Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) · 214 trials list this drug (22 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00251589Phase 1/Phase 2 · terminated A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer (0683-025) · 214 trials list this drug (22 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00363883Phase 2 · terminated Vorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urothelium · 214 trials list this drug (22 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01386398Phase 3 · withdrawn Vorinostat With or Without Bortezomib in Treating Patients With Refractory or Recurrent Stage IIB, Stage III, or Stage IV Cutaneous T-Cell Lymphoma · 214 trials list this drug (22 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01378481Phase 1 · terminated High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma · 214 trials list this drug (22 active) | — | — | Adult Mixed Glioma,Adult Anaplastic Astrocytoma,Adult Anaplastic Oligodendroglioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00365599Phase 2 · completed Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer · 214 trials list this drug (22 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00481078Phase 2 · completed Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer · 214 trials list this drug (22 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00787527Phase 1/Phase 2 · completed SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma · 214 trials list this drug (22 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00275080Phase 1 · completed Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia · 214 trials list this drug (22 active) | — | — | Adult Solid Neoplasm,Non-Hodgkin Lymphoma,Secondary Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00134043Phase 2 · completed Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer · 214 trials list this drug (22 active) | — | — | Thyroid Gland Follicular Carcinoma,Malignant Thyroid Gland Neoplasm,Thyroid Gland Medullary Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02114502Phase 2 · withdrawn Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma · 214 trials list this drug (22 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00942266Phase 2 · completed Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment · 214 trials list this drug (22 active) | — | — | Colon Adenocarcinoma,Malignant Colon Neoplasm,Malignant Rectal Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00217412Phase 1 · completed Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia · 214 trials list this drug (22 active) | — | — | Childhood Solid Neoplasm,Juvenile Myelomonocytic Leukemia,Childhood Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00258349Phase 1/Phase 2 · completed Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer · 214 trials list this drug (22 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00330161Phase 2 · completed Vorinostat in Treating Patients With Progressive Metastatic Prostate Cancer · 214 trials list this drug (22 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00132028Phase 2 · completed Vorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's Lymphoma · 214 trials list this drug (22 active) | — | — | Adult Hodgkin Lymphoma,Adult Nodular Lymphocyte Predominant B-Cell Lymphoma,Adult Favorable Prognosis Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00238303Phase 2 · completed Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme · 214 trials list this drug (22 active) | — | — | Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Brain Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00336141Phase 1 · completed Vorinostat and IV Fluorouracil/Leucovorin (5FU/LV) in Patients With Metastatic Colorectal Cancer · 214 trials list this drug (22 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00305773Phase 2 · completed Vorinostat in Treating Patients With Acute Myeloid Leukemia · 214 trials list this drug (22 active) | — | — | Secondary Acute Myeloid Leukemia,Adult Acute Erythroid Leukemia,Adult Acute Megakaryoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00641706Phase 2 · completed Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme · 214 trials list this drug (22 active) | — | — | Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Brain Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00937495Phase 2 · completed Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue Sarcoma · 214 trials list this drug (22 active) | — | — | Adult Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00810602Phase 1/Phase 2 · completed Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant · 214 trials list this drug (22 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00227513Phase 1 · completed Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors · 214 trials list this drug (22 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00324480Phase 1 · completed Vorinostat and Alvocidib in Treating Patients With Advanced Solid Tumors · 214 trials list this drug (22 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00499811Phase 1 · completed Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction · 214 trials list this drug (22 active) | — | — | Adult Solid Neoplasm,Anaplastic Large Cell Lymphoma,Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01695057NA · withdrawn Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast Cancer · 214 trials list this drug (22 active) | — | — | Malignant Breast Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01600742Phase 2 · terminated Vorinostat and Concurrent Whole Brain Radiotherapy for Brain Metastasis · 214 trials list this drug (22 active) | — | — | Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00243100Phase 1 · completed Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors · 214 trials list this drug (22 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00416130Phase 1/Phase 2 · unknown Clinical Trial of SAHA in Patients With Breast Cancer · 214 trials list this drug (22 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00138177Phase 1 · completed Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors · 214 trials list this drug (22 active) | — | — | Adult Solid Neoplasm,Malignant Colon Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00331513Phase 1 · completed Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes · 214 trials list this drug (22 active) | — | — | Myelodysplastic Syndrome,Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00762255Phase 1 · completed A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma · 214 trials list this drug (22 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00331955Phase 1 · completed Vorinostat and Doxorubicin in Treating Patients With Metastatic or Locally Advanced Solid Tumors · 214 trials list this drug (22 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00994500Phase 1 · completed Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma · 214 trials list this drug (22 active) | — | — | Childhood Solid Neoplasm,Choroid Plexus Neoplasm,Central Nervous System Medulloepithelioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00537121Phase 1 · completed Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer · 214 trials list this drug (22 active) | — | — | Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm,Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00635791Phase 1 · completed Phase I Study of Vorinostat and Sorafenib in Advanced Cancer · 214 trials list this drug (22 active) | — | — | Malignant Solid Neoplasm,Lung Non-Small Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005634Phase 1 · completed Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy · 214 trials list this drug (22 active) | — | — | Adult Solid Neoplasm,Leukemia,Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |